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A Ab bs st tr ra ac ct t
High-throughput technologies for DNA sequencing and for analyses of transcriptomes,
proteomes and metabolomes have provided the foundations for deciphering the structure,
variation and function of the human genome and relating them to health and disease states. The
increased efficiency of DNA sequencing opens up the possibility of analyzing a large number of
individual genomes and transcriptomes, and complete reference proteomes and metabolomes are
within reach using powerful analytical techniques based on chromatography, mass spectrometry
and nuclear magnetic resonance. Computational and mathematical tools have enabled the
development of systems approaches for deciphering the functional and regulatory networks
underlying the behavior of complex biological systems. Further conceptual and methodological
developments of these tools are needed for the integration of various data types across the
multiple levels of organization and time frames that are characteristic of human development,
physiology and disease. Medical genomics has attempted to overcome the initial limitations of
genome-wide association studies and has identified a limited number of susceptibility loci for
many complex and common diseases. Iterative systems approaches are starting to provide deeper
insights into the mechanisms of human diseases, and to facilitate the development of better
diagnostic and prognostic biomarkers for cancer and many other diseases. Systems approaches
will transform the way drugs are developed through academy-industry partnerships that will
target multiple components of networks and pathways perturbed in diseases. They will enable
medicine to become predictive, personalized, preventive and participatory, and, in the process,
concepts and methods from Western and oriental cultures can be combined. We recommend
that systems medicine should be developed through an international network of systems biology
and medicine centers dedicated to inter-disciplinary training and education, to help reduce the
gap in healthcare between developed and developing countries.
Systems biology is developing rapidly. It is an integrative
research strategy designed to tackle the complexity of
biological systems and their behavior at all levels of
organization (from molecules, cells and organs to organisms
and ecosystems) in normal and perturbed conditions. It is
based on an understanding of biological functions as system
properties that are different from those of the individual
interacting components (reviewed in [1-9]). It integrates the
mass of data that has been collected with various global
measurement technologies (techniques that look at the com-
plete set of genes, proteins or other features in an organism),
in order to formulate predictive mathematical and compu-
tational models of functional and regulatory biological
networks. Specific biological hypotheses can thus be tested
by designing a series of perturbation experiments. It thus
combines data-driven (bottom-up) [10] and model-driven
(top-down) [11] approaches into a question-driven (middle-
out) inquiry in search of basic principles [12-14]. In the end,
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© 2009 BioMed Central Ltd systems approaches must be driven by high-quality
hypothesis-driven biology and not just by data-accumulating
technologies or high-performance computational modeling.
Although systems biology has ancient roots in physiology,
biochemistry, and molecular and cellular biology, its current
development is the result of recent advances in genomics
and bioinformatics, which were made possible by the
continuous development of high-throughput experimental
and computational platforms. The field is also revisiting
previous attempts at modeling biological complexity, by
taking advantage of insights from system theory [15] and
engineering sciences [16,17]. It forms the basis for an
extension of genetic engineering into synthetic biology:
designing and building biological systems with new
properties from modular components [18-21].
Evolution, development, physiology and disease are
viewed in systems biology as dynamic processes that
operate on widely different scales in space and time
between biological states that are constrained by inter-
relationships among pathway and network components.
In this context, detecting, understanding and treating
disease translates into identifying and manipulating
global perturbed networks rather than focusing only on
unique failing components.
Here we review how medical genomics [22,23], based on
recent advances in high-throughput experimental and
computational technologies, is evolving in the context of
systems biology into a more prospective systems medicine
[24-31]. This new kind of medicine will be able to overcome
the current limitations of disease complexity (through
stratification of patients and diseases by molecular
diagnostics) and drug discovery (through the analysis and
targeting of disease-perturbed networks) [32-35]. We discuss
some of the technological, conceptual and organizational
challenges that we will face in implementing this new vision
and practice of biology and medicine, and we argue that it
offers new opportunities to more efficiently tackle key medical
problems in both developed and developing countries.
T Te ec ch hn no ol lo og gy y   i is s   m mo ov vi in ng g   g ge en no om mi ic cs s   f fr ro om m   s st tr ru uc ct tu ur re e   t to o
f fu un nc ct ti io on n
The initial sequencing of the human genome was made
possible by the automation of the DNA sequencing chemistry
and by the development of data-acquisition tools and
software for the reliable interpretation and assembly of the
DNA sequence. It required a multi-billion-dollar investment
and the participation of thousands of researchers in the
public and private sectors over more than a decade. It came
together with the sequencing of genomes in a variety of
microorganisms, animals and plants. All these efforts
combined served as test cases to trigger sustained technology
developments.
With the next-generation DNA mega-sequencing technolo-
gies currently available, which enable the collection of billions
of nucleotides in single instrument runs [36], it is now
possible to sequence and assemble a human genome in a
matter of weeks at a small fraction of the cost of the refer-
ence genome [37]. With both incremental progress and the
introduction of third-generation sequencing technologies, it
may soon become possible to collect large numbers of indi-
vidual genomes in days for US$1,000 or less and ascertain
their unique variations. This opens up the possibility of a
Personal Genome Project to find correlations between geno-
types and normal or diseased phenotypes [38]. In parallel,
over a period of more than 30 years, successive generations
of increasingly miniaturized DNA arrays have been used for
expression profiling, benefiting from the extensive
sequencing of partial and complete cDNA collections. Micro-
array technology, because of its intrinsic complexity and that
of the transcriptome, has reached an intermediate stage of
maturity compared with sequencing [39]; it is possible to
detect variations in expression of many but not all gene
transcripts under normal and perturbed conditions.
Early on, insufficient attention was paid by users of current
microarray platforms to proper design and quality assess-
ment, which is needed to control for variation in the large
number of biological and experimental parameters involved.
This compromised the usefulness of these platforms, for
example in the development of classification and predictive
biomarkers [40-42]. The introduction of standards and
guidelines for complete microarray workflows [43] is help-
ing to rectify the problem; these need to cover all aspects,
from RNA integrity assessment [44,45] to data analysis and
reporting [46,47]. There has also been constant progress in
the use of advanced statistical methods for multivariate
classification [48] and for gene-set enrichment analysis [49]
of expression profiles. At the same time, it has become clear
through the combination of tiling arrays and systematic
sequencing that a larger fraction of the human genome is
transcribed into diverse types of RNA than was previously
thought [50,51]. The increased power and reduced cost of
deep sequencing thus means that it is starting to compete
with high-density microarrays [52,53], to the extent that
some believe this is marking the beginning of the end of
microarrays [54].
However, given that each new generation of tools takes
several years to mature, it is most likely that sequencing
and microarrays will continue to coexist. Microarrays will
probably be increasingly used for specialized applications,
such as those related to transcription regulation,
epigenetic modifications, and selection of subfractions of
individual genomes for sequencing (for example, exons,
highly conserved regions, and so on); whereas mega-
sequencing will be used for deep exploration of
transcriptomes. The results of transcriptome analyses will
increasingly be validated by emerging technologies that
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PCR [55] or multiplex direct visualization and counting of
RNA molecules; the latter technology has the added
advantage of avoiding biases resulting from reverse
transcription [56].
From the genome and transcriptome sequences, it has been
possible to derive a relatively complete parts list of genes
and, by extension, of proteins, thus revolutionizing the field
of proteomics. It is crucial to note that mass spectrometry is
effective in the identification of peptides, and not of
complete proteins. In order to identify and quantify interest-
ing proteins by mass spectrometry, either through shotgun
or directed approaches, an investigator therefore needs to
know the sequence of the peptides obtained by enzymatic
digestion of those proteins. The current generation of
proteomic tools that are based on high-performance combi-
nations of chromatography and mass spectrometry thus
enable the identification of a growing number of proteins,
and can also identify them over a wide range of abundances
and when they have complex secondary modifications. The
technology can achieve this using fragmentation, peptide
sequencing and, as noted above, comparison with proteins
that have been predicted from genome and transcriptome
sequences [57-59].
Recent results indicate that the description of complete
reference proteomes is now within reach in advanced
centers, using multiple reaction monitoring combined with
mass spectrometry; this combination is the most powerful
and rapid targeted approach currently available [60-62].
These complete proteomes will probably serve as a reference
for the subsequent development of simpler targeted assays
[63], which will be complemented by array-based global
surveys using affinity-based protein-specific reagents
[64-66], and in certain cases, by single-cell proteomics using
high-speed flow cytometry [67,68]. Furthermore, ongoing
developments using nanomaterials are expected to provide
next-generation proteomic analysis tools [69].
In addition to using chromatography and mass spectro-
metry, metabolomics is also taking advantage of nuclear
magnetic resonance to analyze complex sets of metabolites
in body fluids and tissues that reflect normal and disease
states, and to study interactions with the gut microbial flora
and environment factors [70-72]. Special attention is being
paid increasingly to lipidomics [73,74] and glycomics [75,76]
as complementary sources of biomarkers.
The development of each of these global high-throughput
technologies has triggered implementation of standard
operating procedures, ontologies and quality-assurance
pipelines for data collection and analysis using dedicated
software and databases, and this has required a change in
culture in biological laboratories [77-81]. In turn, the need
for independent validation of the results obtained with
these ‘omics’ technologies has stimulated the emergence of
large-scale  chemical-genetics and functional screens using
cell microarrays and RNA interference [82-84].
C Co om mp pu ut ta at ti io on na al l   a an nd d   m ma at th he em ma at ti ic ca al l   t to oo ol ls s   e em mp po ow we er r
s sy ys st te em ms s   b bi io ol lo og gy y
With the increasing availability of large amounts of data
and curated information on all types of biological system
components, the focus has progressively shifted to
identifying the interactions they make, forming transient
or permanent macromolecular structures with particular
biological functions, and to looking at how the interactions
can be represented computationally as metabolic, protein,
microRNA and gene-regulatory networks [85,86]. This
emerging ‘network biology’ is taking advantage of advances
in functional genomics, computational methods,
computing power, and network and graph theories. It is
reviving the advanced biochemistry that has been
published in textbooks and illustrated in static wall charts
for decades [87-89]. Network biology is revealing the
existence of modular structures in biological networks that
may explain the robustness of biological systems when
they are exposed to changing environments [90-93].
The initial attempts to identify biologically relevant
protein-protein interactions using the yeast two-hybrid
technology were plagued by high rates of artifactual events.
Thanks to methodological improvements, the rate of false
positives has been reduced. The careful curation of these
interactions from targeted assays reported in the literature
has led to high quality but incomplete maps of the human
interactome, which are now available and which are
expected to be extended to more complete coverage in the
future [94-96]. Given that biological networks change their
architectures dynamically during biological processes, such
as development, physiological responses and disease, their
complete determination will continue to be an enormous
scientific and technological challenge.
Similar progress is being made in assembling human
signaling, metabolic and gene regulatory networks that are
based on metabolites, RNA and microRNA expression,
protein-protein and protein-DNA interactions [97-100].
This has required the development of standardized
languages and software tools for graphical representation of
molecular interaction maps and computation of predictive
and dynamic models [101-105]. Integration methodologies
have also been essential to combine diverse types of data
that have been collected with different platforms and in
many laboratories, and thus to generate testable hypotheses
[106-110]. A limitation that is often overlooked is that the
quality of the annotation resources is very variable [111-
114]. This has triggered sustained community efforts for
integrative annotation, which combine automated
computation with human-supervised curation, the use of
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the semantic web [115-120].
In general, the models derived from these integrated
methodologies have not yet reached the level of detail and
precision of those obtained through highly focused systems
biology approaches, such as those that describe the
transcriptional control in a free living microorganism under
changing environmental conditions [121] or the early phases
of development of the sea urchin [122]. It seems likely that the
same operating principles of network structure and dynamics
that have been revealed in these latter model systems will be
relevant to human physiology and pathology [123].
In a parallel track, the Physiome Project is building on over
half a century of molecular modeling of excitable cells that
used ordinary and partial differential equations and is also
using finite element lattices for geometric modeling of
complete human organs. This project has steadily developed
a computational physiology framework with its own model-
ing language [124,125], and initial models of the beating
heart, the contracting muscle and the breathing lung are
already available [126,127]. Cell and development simulation
efforts use yet other types of modeling formalisms and
languages, including Boolean networks, cellular automata
and process algebra [128-135], and many others are being
developed in computational neuroscience, which has yet to
merge with systems biology [136].
This diversity of approaches for modeling biological systems
highlights the renewed importance of the contributions of
mathematics, informatics and physics to systems biology
[137-139]. Despite the introduction of novel computational
methods, given that they are often based on distinct or
incompatible principles, it is difficult or impossible to
integrate these methods across the multiple levels of
organization and time-scales characteristic of living systems
[140-142]. Thus, multi-scale integration of different types of
biological information (DNA, RNA, protein, networks,
organelles, cells, tissues, organs, higher level phenotypes,
and so on) remains a major challenge in systems biology.
The plea for more theory by some of the founders of systems
biology must be tempered by the fundamental need to have
theories that closely reflect biological data through
hypothesis-driven model testing [143]. Recent proposals
based on allometric scaling [144] and scale relativity theory
[8,145] may provide the theoretical framework and mathe-
matical tools required to overcome some of these limitations,
and may reveal an important role for small fluctuations in
driving the behavior of biological systems [146,147].
T Th he e   t tr ra an ns si it ti io on n   f fr ro om m   m me ed di ic ca al l   g ge en no om mi ic cs s   t to o   s sy ys st te em ms s
m me ed di ic ci in ne e
With the availability of increasingly powerful high-through-
put technologies, computational tools and integrated
knowledge bases, it has become possible to establish new
links between genes, biological functions and a wide range of
human diseases [148-153]. This is providing signatures of
pathological biology [154] and links to clinical research [155]
and drug discovery [156,157]. These are the hallmarks of
systems medicine as it is emerging from the initial, more
targeted efforts of medical genomics.
Success in the identification of mutations affecting the
hundreds of genes involved in inherited disorders has been a
major outcome of the first generations of genetic maps of the
human genome. In contrast, the reported associations
between genetic polymorphisms and common complex traits
have rarely been confirmed in independent studies. The
situation has changed in the past two years [158], with the
availability of dense maps of single nucleotide poly-
morphisms and the adoption by the community of medical
geneticists of consensus guidelines for the optimal design of
genome-wide or targeted association studies, including rules
for independent replication [159,160]. Despite the very
significant problems with signal-to-noise ratios that still
severely limit the conclusions that can be drawn from such
studies, progress has been made in identifying susceptibility
loci involved in, for example, diabetes [161-163], obesity
[164], and breast or lung cancer [165-167]. In the case of
lung cancer, however, different scientific groups interpret
the functional significance of the results differently. Further
progress is expected now that the important role of other
forms of genomic polymorphisms between individuals,
including monozygotic twins, has been recognized; these
include the effects of copy number variations and epigenetic
modifications [168-170].
Taking advantage of expression-profiling surveys performed
in extended human populations [171-174], systems biologists
have started integrating physiopathology, network biology
and DNA variations [175-177], providing novel insights into
the mechanisms of various diseases, such as diabetes [178]
and obesity [179]. Cancer, which can be considered as a
prototypical systems disease, has benefited greatly from
systems approaches and has served to a large extent as a test
case to develop them [180-184]. This work has highlighted
the importance of epigenetic variations in controlling
transcriptional programs sustaining differentiation of
normal and cancer stem cells [185,186].
Transcriptome and proteome analyses of collections of cancer
samples, combined with functional annotation and modeling
of modulated molecular pathways and networks, have
revealed useful biomarkers for the classification and diagnosis
of cancer subtypes, the prognosis of patient outcomes, the
prediction of treatment responses and the identification of
perturbation targets for drug development [187-196]. As an
illustration of the value of systems approaches, the predictive
power and robustness of biomarkers can be significantly
increased by integrating transcriptome profiles with
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subnetwork modules [197]. In a similar way, systems
approaches are starting to have an impact on the study of
immunological diseases [198], inflammation [199],
infectious diseases such as tuberculosis [200], neurological
diseases such as autism [201] and Alzheimer’s [202],
respiratory diseases such as asthma [203], cardiovascular
and metabolic diseases [204-206] and many others. A
common biological theme that emerges from many of these
studies is that the control and dysfunction of energy
metabolism has a central role. This is illustrated in cardiac
system bioenergetics by the Frank-Starling law of cardiac
muscle contraction [207,208], in cancer by the Warburg
effect (the dependence of cancer cells on aerobic glycolysis)
[209], and in neurodegenerative diseases and aging by
increases of oxidative stress [210,211].
W Wh he en n   E Ea as st t   a an nd d   W We es st t, ,   N No or rt th h   a an nd d   S So ou ut th h   m me ee et t   t to o
d de ev ve el lo op p   s sy ys st te em ms s   m me ed di ic ci in ne e
Systems approaches are likely to help elucidate the
mechanisms underlying the fundamental biological
processes perturbed in human diseases and, in doing so,
enable more efficient therapeutic interventions. They will
change how drug targets are identified. Novel treatments
will include multiple drugs interacting with key inter-
connected components within functional network modules,
each contributing a fraction of the effects of perturbations
that cause disease. It is likely that they will be effective only
when combined with the multiple interactions of other
drugs. This reflects the way that biological systems function
and are organized to maintain themselves and constantly
adapt to developmental, environmental, physiological or
pathological changes. It is also reminiscent of the principles
underlying traditional medicines developed empirically
within Chinese or Indian cultures for the past several
thousand years. Initial attempts at systems approaches,
using transcriptome and proteome analyses to study the
synergistic effect of combining Western drugs with Chinese
medicine components in the treatment of leukemia, are
starting to bear fruit [192,212,213]. Similarly, metabolome
studies are being used to analyze the composition of herbal
medicines and explain their properties [214], and to
establish how gut microorganisms modulate human
metabolic phenotypes and respond to the health or disease
state of their host [215].
Systems approaches are also providing evidence on the
effects of stress, relaxation, nutrition and lifestyle on the
course of health and diseases [216,217]. Systems studies
need to pay greater attention to gender, age and time differ-
ences in diet, disease development and treatment
administration and responses [218-221]. These factors can
be monitored, for example, using non-invasive metabo-
lomics surveys of urine [222,223], and they will increasingly
also be monitored using molecular fingerprints of blood
proteins that indicate relevant physiological or disease
states. Other important contextual phenomena that also
need to be taken into account in future studies include the
effects of the mother’s genetic makeup or feeding habits on
the development of the fetus and the timing of its biological
clock, which have been observed in animal models
[224,225], and the central role of the major histocom-
patibility complex in the development and control of disease
through immunity and inflammation [226-229].
Thus, systems biology will provide the foundation for a
prospective medicine that will be predictive, personalized,
preventive and participatory [230], and that takes into
account the multiple components of the healthcare system,
including disease outcomes as reported by the patients
themselves, and public and private organizations involved in
healthcare management. [231]. In addition to genomics and
systems biology, the key components that will ensure the
successful development of systems medicine are the model-
ing of physiopathology in a clinical-practice context [232],
imaging [233], and bio-banking that complies with strictly
enforced ethical regulations [234-236]. These intrinsically
interdisciplinary endeavors will require dedicated centers
and networks in which scientists of all disciplines can work
together [237-239], with careful attention to clinical practice
and education [240,241].
In order to implement this vision, academia and industry
will have to work closely together in an open-access and
open-source environment focusing on the initial, pre-
competitive phase of the drug discovery process. This will
enable the subsequent development of valuable intellectual
property that will result in more effective diagnostic and
therapeutic approaches. Such developments might seem
very far from the priorities of the less developed countries, in
which the majority of the population is excluded from basic
medical care. These countries are facing major challenges to
their ability to fight infectious diseases and malnutrition, a
situation aggravated by the shortage of safe drinking water
and economic poverty [242]. International initiatives are
underway to tackle these challenges in global health, such as
support for engagement of communities in research and
formulation of a research and development treaty that will
redefine the rules for clinical trials and management of
intellectual property rights [243,244].
Strategic partnerships, such as the Systemoscope Con-
sortium, propose guidelines and strategies for ‘rethinking
research, understanding life, improving health’ [245]. We
support the view that leaders of the developing countries
should consider establishing integrative systems biology and
medicine centers networked with those emerging in the
developed countries. Implementing such centers at the heart
of their much-needed healthcare infrastructures would
ensure immediate access to the most advanced technologies,
and allow developing countries to build an essential
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populations. These centers would provide a route to the
adequate healthcare that is required to reduce the ever-
growing gap between the developed and underdeveloped
nations.
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